Literature DB >> 6195954

Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis.

W G Bradley, P Good, C G Rasool, L S Adelman.   

Abstract

Phrenic nerves of 11 patients with amyotrophic lateral sclerosis studied postmortem contained only 33% of the normal number of large myelinated fibers (9 controls; p less than 0.001). In the phrenic nerves of these patients, there were 18% fewer large myelinated fibers in the distal segment than in the proximal segment (p less than 0.025). The ratio of axonal circumference to myelin lamellae in large myelinated fibers in the distal segment was 34% greater than that in control fibers (p less than 0.002). The proportion of acute axonal degeneration was the same at all levels (48.0 +/- 13.7%). Sural nerves of 21 patients with amyotrophic lateral sclerosis had more acute axonal degeneration and 30% fewer myelinated fibers (p less than 0.05) than controls; evidence of degeneration also extended to unmyelinated fibers. The amount of axonal transport of acetylcholinesterase in 9 sural nerves determined in vitro was reduced by 24% (p less than 0.05) and the apparent transport rate was reduced by 44% (p less than 0.01) compared with 4 controls. These findings show that in amyotrophic lateral sclerosis a small degree of dying-back change and of distal axonal atrophy is superimposed on the degeneration of motor neuron cell bodies, and that the disease effects spread beyond the motor neurons.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6195954     DOI: 10.1002/ana.410140304

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  39 in total

1.  Sensory nerve pathology in amyotrophic lateral sclerosis.

Authors:  T Heads; M Pollock; A Robertson; W H Sutherland; S Allpress
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Immunoglobulins from amyotrophic lateral sclerosis patients enhance spontaneous transmitter release from motor-nerve terminals.

Authors:  O D Uchitel; S H Appel; F Crawford; L Sczcupak
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

3.  Changes of unmyelinated nerve fibers in sural nerve in amyotrophic lateral sclerosis, Parkinson's disease and multiple system atrophy.

Authors:  T Kanda; H Tsukagoshi; M Oda; K Miyamoto; H Tanabe
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

Review 4.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

5.  Morphological and functional changes in innervation of a fast forelimb muscle in SOD1-G85R mice.

Authors:  Khanh T Nguyen; Zhongsheng Zhang; Ellen F Barrett; Gavriel David
Journal:  Neurobiol Dis       Date:  2012-07-17       Impact factor: 5.996

6.  Electrical stimulation of transplanted motoneurons improves motor unit formation.

Authors:  Yang Liu; Robert M Grumbles; Christine K Thomas
Journal:  J Neurophysiol       Date:  2014-05-21       Impact factor: 2.714

7.  Distal hereditary upper limb muscular atrophy.

Authors:  D W Gross; A H Rajput; M Yeung
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-02       Impact factor: 10.154

8.  Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study.

Authors:  K Pugdahl; A Fuglsang-Frederiksen; M de Carvalho; B Johnsen; P R W Fawcett; A Labarre-Vila; R Liguori; W A Nix; I S Schofield
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-07       Impact factor: 10.154

9.  Intramuscular nerves in motor neurone disease. A quantitative ultrastructural study.

Authors:  C P Case; M Jelaca
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 10.  Amyotrophic lateral sclerosis.

Authors:  Lokesh C Wijesekera; P Nigel Leigh
Journal:  Orphanet J Rare Dis       Date:  2009-02-03       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.